💨 Abstract

The Indian government has proposed extending the deadline for small and medium-scale drug manufacturers to adopt Good Manufacturing Practices (GMP) by a year, till December 2025, due to requests from industry associations and Rashtriya Swayamsevak Sangh-backed organization Laghu Udyog Bharti. The extension is intended to provide these companies with more time to upgrade their facilities without facing closure.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖